UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of report (Date of earliest event reported): May 9, 2012

IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

Delaware
000-19271
01-0393723
(State or other jurisdiction
(Commission File Number)
(IRS Employer Identification No.)
of incorporation)
   


One IDEXX Drive, Westbrook, Maine
04092
(Address of principal executive offices)
(ZIP Code)

207.556.0300
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. to Form 8-K):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 


 
 
 
 


Item 5.07
Submission of Matters to a Vote of Security Holders.


(a)
The Annual Meeting of Stockholders (the “Annual Meeting”) of IDEXX Laboratories, Inc. (the “Company”) was held on May 9, 2012.


(b)
The Company’s stockholders elected each of the Company’s three nominees for Class I director; approved the nonbinding advisory resolution on the Company’s executive compensation program; and ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2012 fiscal year.


Proposal 1:
Election of Directors

Nominees
 
Votes For
 
Votes Withheld
 
Broker Nonvotes
William T. End
 
46,905,341
 
586,076
 
5,625,396
Barry C. Johnson, PhD
 
47,240,928
 
250,489
 
5,625,396
Brian P. McKeon
 
47,248,543
 
242,874
 
5,625,396


Proposal 2:
Advisory Vote to Approve Executive Compensation

For
44,243,499
Against
729,310
Abstain
2,518,608
Broker Nonvotes
5,625,396


Proposal 3:
Ratification of Appointment of Independent Registered Public Accounting Firm

For
52,638,569
Against
431,634
Abstain
46,610
Broker Nonvotes
0


 
2

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
IDEXX LABORATORIES, INC.
   
   
Date: May 10, 2012
By:
/s/ Conan R. Deady
   
Conan R. Deady
   
Corporate Vice President, General Counsel and Secretary


 
3